Antidepressant use for major depressive disorder (MDD) is frequently associated with sexual dysfunction.
Aims:
Cross-sectional and longitudinal relationships between antidepressant treatment outcomes and sexual functioning (SF) were evaluated separately for males and females receiving escitalopram. We further assessed the association between pre- and posttreatment SF.
Methods:
In all, 208 of the 211 CAN-BIND-1 trial participants (77 males and 131 females) with MDD and detectable drug blood levels were eligible for the analyses. All received escitalopram (10–20 mg) for 8 weeks. At baseline and Week 8, participants completed the Montgomery–Åsberg Depression Rating Scale (MADRS) and the SexFx scale, which measures sexual satisfaction and SF frequency. Mixed-model repeated measures assessed baseline to Week 8 SF changes among participants with different response/remission statuses. Multiple linear regression analyses examined SF differences between treatment outcomes at Week 8 as well as associations between pretreatment and eventual SF.
Results:
For both sexes, overall sexual satisfaction improved among responders but not among nonresponders (p < 0.05). For females, overall SF frequency did not change significantly over time regardless of response status. For males, overall SF decreased significantly among nonresponders; orgasm decreased significantly among nonresponders and, to a lesser extent, among responders (p < 0.05). For both sexes, pretreatment SF was significantly associated with SF at Week 8 across all domains (p < 0.05).
Conclusion:
For both sexes, sexual satisfaction improves with response to escitalopram. For females, the response does not correspond to improvements in SF frequency. For males, SF frequency, particularly that of orgasm, declines regardless of response/nonresponse.
BaldwinDSCooperJAHuusomAK, et al. (2006) A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder. International Clinical Psychopharmacology21(3): 159–169.
2.
BaldwinDSReinesEHGuitonC, et al. (2007) Escitalopram therapy for major depression and anxiety disorders. The Annals of Pharmacotherapy41(10): 1583–1592.
3.
BaldwinDSMansonCNowakM (2015) Impact of antidepressant drugs on sexual function and satisfaction. CNS Drugs29(11): 905–913.
4.
BalonRSegravesRT (2008) Survey of treatment practices for sexual dysfunction(s) associated with anti-depressants. Journal of Sex & Marital Therapy34(4): 353–365.
5.
BossiniLColucciaACasolaroI, et al. (2015) Off-label trazodone prescription: Evidence, benefits and risks. Current Pharmaceutical Design21(23): 3343–3351.
6.
CarvalhoAFSharmaMSBrunoniAR, et al. (2016) The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: A critical review of the literature. Psychotherapy and Psychosomatics85(5): 270–288.
7.
ChokkaPRHankeyJR (2018) Assessment and management of sexual dysfunction in the context of depression. Therapeutic Advances in Psychopharmacology8(1): 13–23.
8.
CiprianiAFurukawaTASalantiG, et al. (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis. The Lancet (London, England)391(10128): 1357–1366.
9.
ClaytonAHMcGarveyELClavetGJ (1997) The Changes in Sexual Functioning Questionnaire (CSFQ): Development, reliability, and validity. Psychopharmacology Bulletin33(4): 731–745.
10.
ClaytonAMontejoAL (2006) Major depressive disorder, antidepressants, and sexual dysfunction. The Journal of Clinical Psychiatry67Suppl 6: 33–37.
11.
ClaytonAHCroftHAHorriganJP, et al. (2006a) Bupropion extended release compared with escitalopram: Effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. The Journal of Clinical Psychiatry67(5): 736–746.
12.
ClaytonAKellerAMcGarveyEL (2006b) Burden of phase-specific sexual dysfunction with SSRIs. Journal of Affective Disorders91(1): 27–32.
13.
ClaytonAKornsteinSPrakashA, et al. (2007) Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. The Journal of Sexual Medicine4(4 Pt 1): 917–929.
14.
ClaytonAHEl HaddadSIluonakhamheJP, et al. (2014) Sexual dysfunction associated with major depressive disorder and antidepressant treatment. Expert Opinion on Drug Safety13(10): 1361–1374.
15.
CoronaGRiccaVBandiniE, et al. (2009) Selective serotonin reuptake inhibitor-induced sexual dysfunction. The Journal of Sexual Medicine6(5): 1259–1269.
16.
DueñasHLeeABrnabicAJ, et al. (2011) Frequency of treatment-emergent sexual dysfunction and treatment effectiveness during SSRI or duloxetine therapy: 8-week data from a 6-month observational study. International Journal of Psychiatry in Clinical Practice15(2): 80–90.
17.
FriedEINesseRM (2015) Depression sum-scores don’t add up: Why analyzing specific depression symptoms is essential. BMC Medicine13: 72.
18.
GartlehnerGHansenRAMorganLC, et al. (2011) Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: An updated meta-analysis. Annals of Internal Medicine155(11): 772–785.
19.
HensleyPLNurnbergHG (2002) SSRI sexual dysfunction: A female perspective. Journal of Sex & Marital Therapy28Suppl 1: 143–153.
20.
HothornTBretzFWestfallP, et al. (2016) Package “multcomp.” Simultaneous inference in general parametric models. Project for Statistical Computing, Vienna, Austria.
21.
IshakWWChristensenSSayerG, et al. (2013) Sexual satisfaction and quality of life in major depressive disorder before and after treatment with citalopram in the STAR*D study. The Journal of Clinical Psychiatry74(3): 256–261.
22.
JacobsenPLMahableshwarkarARChenY, et al. (2015) Effect of vortioxetine vs. escitalopram on sexual functioning in adults with well-treated major depressive disorder experiencing SSRI-induced sexual dysfunction. The Journal of Sexual Medicine12(10): 2036–2048.
23.
JacobsenPLThorleyEMCurranC (2020) Real-world patient experience with sexual dysfunction and antidepressant use in patients with self-reported depression: A cross-sectional survey study. Neurology, Psychiatry and Brain Research36: 57–64.
24.
KennedySHEisfeldBSDickensSE, et al. (2000) Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. The Journal of Clinical Psychiatry61(4): 276–281.
25.
KennedySHFultonKABagbyRM, et al. (2006) Sexual function during bupropion or paroxetine treatment of major depressive disorder. The Canadian Journal of Psychiatry51(4): 234–242.
26.
KennedySHRizviSFultonK, et al. (2008) A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR. Journal of Clinical Psychopharmacology28(3): 329–333.
27.
KennedySHAndersenHFThaseME (2009) Escitalopram in the treatment of major depressive disorder: A meta-analysis. Current Medical Research and Opinion25(1): 161–175.
28.
KennedySHRizviS (2009) Sexual dysfunction, depression, and the impact of antidepressants. Journal of Clinical Psychopharmacology29(2): 157–164.
29.
KennedySHRizviSJFultonK, et al. (2010) The sex effects scale: Pilot validation in a healthy population. Psychopharmacology Bulletin43(3): 15–25.
30.
KennedySHLamRWRotzingerS, et al. (2019) Symptomatic and functional outcomes and early prediction of response to escitalopram monotherapy and sequential adjunctive aripiprazole therapy in patients with major depressive disorder: A CAN-BIND-1 report. The Journal of Clinical Psychiatry80(2): 18m12202.
31.
KhouzamHR (2017) A review of trazodone use in psychiatric and medical conditions. Postgraduate Medicine129(1): 140–148.
32.
LamRWMilevRRotzingerS, et al. (2016) Discovering biomarkers for antidepressant response: Protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort. BMC Psychiatry16(1): 105.
33.
LandénMErikssonEAgrenH, et al. (1999) Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. Journal of Clinical Psychopharmacology19(3): 268–271.
34.
LevequeESamarronHShawJ (2020) Not into sex: Women’s experiences of treatment-emergent sexual dysfunction. Affilia: Journal of Women and Social Work35(3): 413–433.
35.
LorenzTAMestonCM (2012) Acute exercise improves physical sexual arousal in women taking antidepressants. Annals of Behavioral Medicine: A Publication of the Society of Behavioral Medicine43(3): 352–361.
36.
McGahueyCAGelenbergAJLaukesCA, et al. (2000) The Arizona Sexual Experience Scale (ASEX): Reliability and validity. Journal of Sex & Marital Therapy26(1): 25–40.
37.
MontejoALGarcíaMEspadaM, et al. (2000) [Psychometric characteristics of the psychotropic-related sexual dysfunction questionnaire. Spanish work group for the study of psychotropic-related sexual dysfunctions]. Actas espanolas de psiquiatria28(3): 141–150.
38.
MontejoALLlorcaGIzquierdoJA, et al. (2001) Incidence of sexual dysfunction associated with antidepressant agents: A prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. The Journal of Clinical Psychiatry62Suppl 3: 10–21.
39.
MontejoALCalamaJRico-VillademorosF, et al. (2019) A real-world study on antidepressant-associated sexual dysfunction in 2144 outpatients: The SALSEX I study. Archives of Sexual Behavior48(3): 923–933.
40.
MontgomerySAAsbergM (1979) A new depression scale designed to be sensitive to change. The British Journal of Psychiatry: The Journal of Mental Science134: 382–389.
41.
MontgomerySABaldwinDSRileyA (2002) Antidepressant medications: A review of the evidence for drug-induced sexual dysfunction. Journal of Affective Disorders69(1–3): 119–140.
42.
NurnbergHGHensleyPLGelenbergAJ, et al. (2003) Treatment of antidepressant-associated sexual dysfunction with sildenafil: A randomized controlled trial. JAMA289(1): 56–64.
43.
OzmenlerNKKarlidereTBozkurtA, et al. (2008) Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors. Human Psychopharmacology23(4): 321–326.
44.
PinheiroJBatesDDebRoyS, et al. (2017) Package “nlme.”Linear and nonlinear mixed effects models, version3(1).
45.
R Core Team (2020) R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing. Available at: https://www.R-project.org/
46.
ReichenpfaderUGartlehnerGMorganLC, et al. (2014) Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: Results from a systematic review with network meta-analysis. Drug Safety37(1): 19–31.
47.
RothmoreJ (2020) Antidepressant-induced sexual dysfunction. Medical Journal of Australia212(7): 329–334.
48.
SanchezCReinesEHMontgomerySA (2014) A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?International Clinical Psychopharmacology29(4): 185–196.
49.
Sánchez-FuentesMSantos-IglesiasPSierraJC (2014) A systematic review of sexual satisfaction. International Journal of Clinical and Health Psychology14(1): 67–75.
50.
SeidmanSNRooseSP (2001) Sexual dysfunction and depression. Current Psychiatry Reports3(3): 202–208.
51.
SerrettiAChiesaA (2009) Treatment-emergent sexual dysfunction related to antidepressants: A meta-analysis. Journal of Clinical Psychopharmacology29(3): 259–266.
52.
SheehanDVLecrubierYSheehanKH, et al. (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry59Suppl 20: 22–33; quiz 34–57.
53.
SolmiMMiolaACroattoG, et al. (2021) How can we improve antidepressant adherence in the management of depression? A targeted review and 10 clinical recommendations. Brazilian Journal of Psychiatry43(2): 189–202.
54.
StryjerRSpivakBStrousRD, et al. (2009) Trazodone for the treatment of sexual dysfunction induced by serotonin reuptake inhibitors: A preliminary open-label study. Clinical Neuropharmacology32(2): 82–84.
55.
TaylorMJRudkinLHawtonK (2005) Strategies for managing antidepressant-induced sexual dysfunction: Systematic review of randomised controlled trials. Journal of Affective Disorders88(3): 241–254.
56.
ThaseMEClaytonAHHaightBR, et al. (2006) A double-blind comparison between bupropion XL and venlafaxine XR: Sexual functioning, antidepressant efficacy, and tolerability. Journal of Clinical Psychopharmacology26(5): 482–488.
57.
Van BuurenSGroothuis-OudshoornK (2010) Mice: Multivariate imputation by chained equations in R. Journal of Statistical Software45: 1–68.
58.
WernekeUNortheySBhugraD (2006) Antidepressants and sexual dysfunction. Acta Psychiatrica Scandinavica114(6): 384–397.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
